Lacaba, Nica T.
HRN: 25-75-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2024
CEFUROXIME 500MG (TAB)
09/02/2024
09/08/2024
ORAL
500mg
2 Times A Day
S/P NSVD, RMLE And Repair, Urinary Tract Infection
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes